Akuru Pharma
Akuru Pharma is a biomedical company focusing on exploiting the abnormal expression of transporter proteins in kidney cancer.
Akuru Pharma is active in the biotechnology, health care space based in European Union (EU), Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA), founded in 2016.
The company sits in the biotechnology, health care segment, where it competes on its core product or service.
European Union (EU), Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA) is where the company is located.
Its current recorded stage is Private company.
The company reports a headcount in the c_00011_00050 range.
| Sector | Biotechnology, Health Care |
|---|---|
| Headquarters | European Union (EU), Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA) |
| Founded | 2016 |
| Employees | c_00011_00050 |
| Stage | Private company |
Website: www.akurupharma.com
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account